CompoAtlas

BABY COLIC LIQUID DROPS PROBIOTIC+Vit D 400 IU

Natural health product licensed in Canada

If this product were sold in France

No point flagged by the rules we apply.

A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.

Composition

Medicinal ingredient and sourcePer dosage unit, according to the sourceMaximum per day, adult
Bifidobacterium longum subsp. longum

Source : Bifidobacterium longum subsp. longum - Cellule entière

0.5 Milliards d'UFCNot calculated

Non-medicinal ingredients

Citrate de sodium, L-Cystéine, NA, Dextrose, Dioxyde de silicium, Maltodextrine, Trehalose, D-Mannitol, Ascorbate de sodium

PopulationAgeQuantity per servingFrequency
Enfantsminimum: 1 year ; maximum: 3 years5 Gouttes1 Tous les jours
Nourrissonsminimum: 1 month ; maximum: 12 months5 Gouttes1 Tous les jours

Uses authorised in Canada

Text supplied in English because no French text is available.

Helps (to) maintain/support immune function. Helps in the absorption (and use) of calcium and phosphorus. Helps in the development and maintenance of bones and teeth. Helps to build strong bones and teeth. Helps with immune function. Could promote a favorable gut flora. Helps support intestinal/gastrointestinal health. Source of Probiotics. Helps improve colic symptoms relief in babies/infants such as crying, fussing, or irritability. Helps to reduce crying time and frequency in colicky baby. Provides benefit in crying time and frequency in 7 days. Clinically proven to help provide/improve colic symptoms relief in both, formula and/or breast fed babies/infants with colic syndrome. Clinically proven as an effective therapy to colic syndrome in both, formula and/or breast fed babies/infants and consequently helps improve the quality of life of the parents. Reduction of the total crying time in infants with colic. Helps reduce total crying time in infants with colic. Improvement in colic symptoms, impacting positively in the infant comfort and consequently in the quality of life of the parents. May benefit infants with colic syndrome by reducing daily crying time. Helps reduce the duration of crying episodes in babies/infants by providing gut comfort and colic symptoms relief. Benefit in colic symptom for both formula and breast fed baby.

A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.

Warnings in Canada

No French warning text available in the imported data.

Warnings are available in English on the official record.

Product record

Licence holder
Les Emballages Façoteck
NPN or DIN-HM
80118967
Status
Active licence
Licence date
27 May 2022
Revision date
Not provided
Form
Gouttes orales
Route of administration
Orale
Application type
Générale (non traditionelle)

Source

Official Health Canada record, licence 80118967

Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.

Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)

Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)

The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.

Cite this page: CompoAtlas, “BABY COLIC LIQUID DROPS PROBIOTIC+Vit D 400 IU (Les Emballages Façoteck): composition and ingredients”, https://compoatlas.com/en/supplements/canada/80118967-baby-colic-liquid-drops-probiotic-vit-d-400-iu, updated 27 May 2022.

Enter to analyse, Shift+Enter for a new line